2 lawmakers push for Avandia to be withdrawn from the market

06/28/2010 | Hill, The

A joint statement from Sen. Chuck Grassley, R-Iowa, and Rep. Rosa DeLauro, D-Conn., calls on the FDA to withdraw GlaxoSmithKline's Avandia from the market, after two studies confirmed that the drug poses serious risks in diabetics. The first study showed that Avandia increases patients' risk of heart attack, while the second study found that the drug raises the risk for stroke, heart failure and death.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Medical Director - Physician
Willamette Valley Community Health
Salem, OR